APA (7th ed.) Citation

O, L., N, B., EK, O., J, M., KC, W., A, B., . . . BA, D. (2025). Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma. HemaSphere, 9(7), e70178. https://doi.org/10.1002/hem3.70178

Chicago Style (17th ed.) Citation

O, Landgren, et al. "Current and Future Role of Carfilzomib-based Quadruplet Combinations as Therapy for Newly Diagnosed Multiple Myeloma." HemaSphere 9, no. 7 (2025): e70178. https://doi.org/10.1002/hem3.70178.

MLA (9th ed.) Citation

O, Landgren, et al. "Current and Future Role of Carfilzomib-based Quadruplet Combinations as Therapy for Newly Diagnosed Multiple Myeloma." HemaSphere, vol. 9, no. 7, 2025, p. e70178, https://doi.org/10.1002/hem3.70178.